USANA HEALTH SCIENCES, INC. Additional Paid in Capital, Common Stock
USANA HEALTH SCIENCES, INC. (USNA) had Additional Paid in Capital, Common Stock of $88.11 million as of 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-07-04: Additional Paid in Capital, Common Stock $88.11M.
- 2026-04-04: Additional Paid in Capital, Common Stock $84.73M.
- 2026-01-03: Additional Paid in Capital, Common Stock $83.54M.
- 2025-09-27: Additional Paid in Capital, Common Stock $79.85M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-07-04 | $88.11M 10-Q · filed 2026-08-13 | |
| 2026-04-04 | $84.73M 10-Q · filed 2026-05-12 | |
| 2026-01-03 | $83.54M 10-Q · filed 2026-08-13 | |
| 2025-09-27 | $79.85M 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $76.37M 10-Q · filed 2025-08-05 | |
| 2025-03-29 | $74.87M 10-Q · filed 2025-05-06 | |
| 2024-12-28 | $75.82M 10-K · filed 2026-03-16 | |
| 2024-09-28 | $72.28M 10-Q · filed 2024-11-05 | |
| 2024-06-29 | $68.81M 10-Q · filed 2024-08-06 | |
| 2024-03-30 | $65.11M 10-Q · filed 2024-05-07 | |
| 2023-12-30 | $65.66M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $62.15M 10-Q · filed 2023-11-07 | |
| 2023-07-01 | $59.97M 10-Q · filed 2023-08-08 | |
| 2023-04-01 | $56.35M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $55.60M 10-K · filed 2024-02-27 | |
| 2022-10-01 | $52.24M 10-Q · filed 2022-11-08 | |
| 2022-07-02 | $49.21M 10-Q · filed 2022-08-09 | |
| 2022-04-02 | $45.95M 10-Q · filed 2022-05-11 | |
| 2022-01-01 | $50.01M 10-K · filed 2023-02-28 | |
| 2021-10-02 | $50.95M 10-Q · filed 2021-11-10 | |
| 2021-07-03 | $53.91M 10-Q · filed 2021-08-11 | |
| 2021-04-03 | $54.08M 10-Q · filed 2021-05-11 | |
| 2021-01-02 | $62.46M 10-K · filed 2022-03-01 | |
| 2020-09-26 | $59.01M 10-Q · filed 2020-11-03 | |
| 2020-06-27 | $55.53M 10-Q · filed 2020-08-04 | |
| 2020-03-28 | $52.00M 10-Q · filed 2020-05-05 | |
| 2019-12-28 | $59.45M 10-K · filed 2021-03-02 | |
| 2019-09-28 | $56.89M 10-Q · filed 2019-11-05 | |
| 2019-06-29 | $68.85M 10-Q · filed 2019-08-06 | |
| 2019-03-30 | $69.10M 10-Q · filed 2019-05-07 | |
| 2018-12-29 | $72.01M 10-K · filed 2020-02-25 | |
| 2018-09-29 | $83.22M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $83.54M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $79.43M 10-Q · filed 2018-05-09 | |
| 2017-12-30 | $76.54M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $72.96M 10-Q · filed 2017-11-08 | |
| 2017-07-01 | $79.51M 10-Q · filed 2017-08-09 | |
| 2017-04-01 | $75.70M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $71.50M 10-K · filed 2018-02-28 | |
| 2016-10-01 | $68.94M 10-Q · filed 2016-11-09 | |
| 2016-07-02 | $64.40M 10-Q · filed 2016-08-09 | |
| 2016-04-02 | $59.58M 10-Q · filed 2016-05-11 | |
| 2016-01-02 | $69.73M 10-K · filed 2017-03-01 | $69.74M 10-K · filed 2016-03-01 |
| 2015-10-03 | $78.15M 10-Q · filed 2015-11-12 | |
| 2015-07-04 | $71.74M 10-Q · filed 2015-08-12 | |
| 2015-04-04 | $64.73M 10-Q · filed 2015-05-13 | |
| 2015-01-03 | $61.61M 10-K · filed 2016-03-01 | |
| 2014-09-27 | $38.60M 10-Q · filed 2014-11-06 | |
| 2014-06-28 | $51.92M 10-Q · filed 2014-08-05 | |
| 2014-03-29 | $58.38M 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $54.69M 10-K · filed 2015-03-17 | |
| 2013-09-28 | $52.85M 10-Q · filed 2013-11-07 | |
| 2013-06-29 | $45.78M 10-Q · filed 2013-08-08 | |
| 2013-03-30 | $41.95M 10-Q · filed 2013-05-07 | |
| 2012-12-29 | $43.82M 10-K · filed 2014-03-13 | |
| 2012-09-29 | $49.26M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $47.74M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $52.26M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $49.26M 10-K · filed 2013-03-11 | |
| 2011-10-01 | $46.83M 10-Q · filed 2011-11-09 | |
| 2011-07-02 | $46.88M 10-Q · filed 2011-08-10 | |
| 2011-01-01 | $51.22M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |